By day +100 (the timeframe for classical acute GVHD), the percentage of Tregs and concentration of IFNγ was comparable to healthy donors, suggesting a normalization of the bone marrow microenvironment by day +100. The gene discussed is IFNG; the disease is acute graft versus host disease.